Trump-backed super PAC to host a $1M-per-person fundraiser the day before the White House UFC fight
MAGA Inc., top Trump-backed super PAC, is set to hold a $1 million-per-person fundraiser the day before the UFC matches on the White House grounds.
another news portal
MAGA Inc., top Trump-backed super PAC, is set to hold a $1 million-per-person fundraiser the day before the UFC matches on the White House grounds.
Closing arguments are expected to start Tuesday as jurors were ordered sequestered in their hotel and instructed to stay off social media.
Apple previewed a suite of new parental controls at WWDC 2026 on Monday, introducing tools that give parents more granular authority over what their children
Cipher Digital is raising $810 million from a junk-bond sale to finance a data centre in West Texas that Amazon will lease for 15 years
Volker Turk, the UN’s high commissioner for human rights, warns that ‘children are dying’ as result of US oil blockade.
Award-winning referee Omar Artan was ‘determined to be inadmissible due to vetting concerns’ after arriving in Miami.
Disgraced former Rep. Aaron Schock (R-IL) mounted a political comeback of sorts, Politico reported in a June 8 article, claiming that Venezuela’s vice president had
Crowds in Madrid were delighted to see Pope Leo make a visit to Santa Maria de la Almudena Cathedral with Queen Sofia.
As Apple announced last year, this year’s macOS release will end support for Intel Macs. The macOS 27 Golden Gate release will require a Mac
If you’re using older iPhone or iPad hardware and you’re hoping to keep running Apple’s latest operating systems, this year’s releases bring mostly good news.
The company hopes to raise billions in a highly anticipated public offering that could unlock a new generation of tech industry wealth.
Mr. Bankman-Fried is serving a 25-year prison sentence for fraud related to the collapse of his cryptocurrency exchange, FTX.
A new analysis of a 120-million-year-old fossil suggests at least one pterosaur species shimmered in iridescent greens and magentas.
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.